Related Experiment Video
Updated: Jul 30, 2026
09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
Monoclonal antibodies: methods and clinical laboratory applications
Clinical Physiology and Biochemistry
|January 1, 1983
Summary
Monoclonal antibodies, produced by fusing antibody-secreting cells with myeloma cells, offer high specificity and reproducibility. This technology revolutionizes biological research, diagnostics, and therapeutics.
Area of Science:
- Immunology
- Biotechnology
Background:
- Traditional antibody production methods using conventional antisera face limitations in specificity and reproducibility.
- The development of monoclonal antibody technology by Kohler and Milstein marked a significant advancement.
Purpose of the Study:
- To review the methods and applications of monoclonal antibody production and utilization.
- To highlight the impact of monoclonal antibodies on various fields of biological research and medicine.
Main Methods:
- Somatic cell hybridization: fusing antibody-secreting lymphocytes with myeloma cells to create continuous antibody-producing cell lines.
- In vitro viral transformation of sensitized lymphocytes.
- Hybrid fusion of sensitized lymphocytes with continuous B lymphocyte cell lines.
Main Results:
- Monoclonal antibodies provide solutions to problems associated with conventional antisera, offering enhanced specificity and reproducibility.
- Established methods for producing monoclonal antibodies from various sources, including human, mouse, and rat.
Conclusions:
- Monoclonal antibody technology has broad applications in biological research, including protein/hormone analysis, histocompatibility testing, tumor detection, and immunotherapy.
- The in vitro production of monoclonal antibodies holds significant promise for future diagnostic and therapeutic applications in clinical medicine.
